Relationship between CD14-159C/T gene polymorphism and acute brucellosis risk
Mehdi Moghadampour1, Ebrahim Eskandari-Nasab2, Fatemeh Shabani3
1Department of Microbiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran; Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
The CD14-159C/T gene variant is linked to increased acute brucellosis risk in Iranians. The T allele and specific genotypes (CT, TT) were significantly more common in patients, suggesting a genetic predisposition.
Area of Science:
- Genetics and Infectious Diseases
- Immunogenetics
- Molecular Epidemiology
Background:
- Brucellosis is a significant zoonotic disease with varying susceptibility.
- Genetic factors may influence an individual's risk of developing brucellosis.
- The cluster of differentiation 14 (CD14) gene plays a role in immune response.
Purpose of the Study:
- To examine the association between the CD14-159C/T (rs2569190) gene polymorphism and susceptibility to acute brucellosis.
- To evaluate the role of specific CD14 genotypes and alleles in brucellosis risk within an Iranian population.
Main Methods:
- Case-control study involving 153 Iranian brucellosis patients and 128 healthy controls.
- Genotyping of the CD14-159C/T polymorphism was performed using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR).
Main Results:
- The CD14-159 CT and TT genotypes were significantly associated with an increased risk of brucellosis (OR=1.993, P=0.03; OR=3.869, P=0.01, respectively).
- The T allele was more prevalent in brucellosis patients (61%) compared to controls (45%), indicating it as a risk factor (OR=3.058, P=0.01).
Conclusions:
- The CD14-159C/T gene polymorphism shows suggestive evidence of association with susceptibility to acute brucellosis in the Iranian population.
- This genetic variant may contribute to the risk of developing brucellosis, warranting further investigation.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Probability Laws
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...


